SY1.DE vs. GSK
SY1.DE (Symrise AG) and GSK (GlaxoSmithKline plc) are both stocks. SY1.DE operates in Specialty Chemicals (Basic Materials), while GSK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SY1.DE returned 4.27%/yr vs 4.06%/yr for GSK. At a 0.19 correlation, their price movements are largely independent.
Performance
SY1.DE vs. GSK - Performance Comparison
Loading charts...
Different Trading Currencies
SY1.DE is traded in EUR, while GSK is traded in USD. To make them comparable, the GSK values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, SY1.DE achieves a 11.92% return, which is significantly higher than GSK's 7.43% return. Both investments have delivered pretty close results over the past 10 years, with SY1.DE having a 4.27% annualized return and GSK not far behind at 4.06%.
SY1.DE
- 1D
- 0.11%
- 1M
- 3.01%
- YTD
- 11.92%
- 6M
- 12.41%
- 1Y
- -27.65%
- 3Y*
- -7.34%
- 5Y*
- -6.10%
- 10Y*
- 4.27%
GSK
- 1D
- 2.97%
- 1M
- 3.25%
- YTD
- 7.43%
- 6M
- 7.53%
- 1Y
- 28.02%
- 3Y*
- 15.74%
- 5Y*
- 6.26%
- 10Y*
- 4.06%
SY1.DE vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SY1.DE Symrise AG | 11.92% | -32.12% | 4.14% | -1.02% | -21.26% | 21.29% | 17.92% | 46.96% | -8.82% | 25.52% |
GSK GlaxoSmithKline plc | 7.43% | 33.29% | 1.12% | 6.42% | -29.29% | 36.22% | -24.50% | 32.16% | 19.13% | -14.89% |
Correlation
The correlation between SY1.DE and GSK is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Aug 28, 2007 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SY1.DE vs. GSK — Risk / Return Rank
SY1.DE
GSK
SY1.DE vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Symrise AG (SY1.DE) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SY1.DE | GSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -3.05 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.20 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | 1.57 | -2.33 |
| Martin ratioReturn relative to average drawdown | -1.02 | 3.61 | -4.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SY1.DE | GSK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.02 | 1.06 | -2.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.26 | 0.25 | -0.51 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.19 | 0.18 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | 0.20 | +0.14 |
Drawdowns
SY1.DE vs. GSK - Drawdown Comparison
The maximum SY1.DE drawdown since its inception was -67.13%, which is greater than GSK's maximum drawdown of -44.08%. Use the drawdown chart below to compare losses from any high point for SY1.DE and GSK.
Loading charts...
Drawdown Indicators
| SY1.DE | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.13% | -44.08% | -23.05% |
Max Drawdown (1Y)Largest decline over 1 year | -36.27% | -17.94% | -18.33% |
Max Drawdown (3Y)Largest decline over 3 years | -45.53% | -26.76% | -18.77% |
Max Drawdown (5Y)Largest decline over 5 years | -46.96% | -44.08% | -2.88% |
Max Drawdown (10Y)Largest decline over 10 years | -46.96% | -44.08% | -2.88% |
Current DrawdownCurrent decline from peak | -38.81% | -13.62% | -25.19% |
Average DrawdownAverage peak-to-trough decline | -14.24% | -15.11% | +0.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.55% | 7.78% | +18.77% |
Volatility
SY1.DE vs. GSK - Volatility Comparison
Symrise AG (SY1.DE) has a higher volatility of 7.47% compared to GlaxoSmithKline plc (GSK) at 6.30%. This indicates that SY1.DE's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SY1.DE | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.47% | 6.30% | +1.17% |
Volatility (6M)Calculated over the trailing 6-month period | 19.41% | 18.16% | +1.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.17% | 26.57% | +0.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.52% | 24.95% | -1.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.50% | 22.95% | -0.45% |
Dividends
SY1.DE vs. GSK - Dividend Comparison
SY1.DE's dividend yield for the trailing twelve months is around 1.65%, less than GSK's 3.37% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 3.37% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
SY1.DE Symrise AG | 1.65% | 1.74% | 1.07% | 1.05% | 1.00% | 0.74% | 1.75% | 0.96% | 1.36% | 1.19% | 1.38% | 1.22% |
Financials
SY1.DE vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Symrise AG and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SY1.DE and GSK have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for SY1.DE and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer